Remdesivir
What's New
Last Posted: Nov 22, 2022
- Use of whole genome sequencing to identify low-frequency mutations in COVID-19 patients treated with remdesivir
K Nirmalarajah et al, MEDRXIV, November 22, 2022 - In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
E Takashita et al, NEJM, November 16, 2022 - Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants
P Jittamala et al, MEDRXIV, October 19, 2022 - Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.
Takashita Emi et al. The New England journal of medicine 2022 3 - Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 - United States, March 2020-August 2021.
Wiltz Jennifer L et al. MMWR. Morbidity and mortality weekly report 2022 1 (3) 96-102 - Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021
JL Witz et al, MMWR, January 14, 2022 - SARS-CoV-2 dependence on host pathways
JP Wong et al, Science, February 26, 2021 - Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments
K Kupferschmidt, Science, October 16, 2020 - Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results
WHO Solidarity Trial Consortium, MEDRXIV, October 15, 2020 - Remdesivir — An Important First Step
R Dolin et al, NEJM, May 27, 2020 - Remdesivir for the Treatment of Covid-19 — Preliminary Report
JH Beigel et al, NEJM, May 22, 2020 - NIH clinical trial testing antiviral remdesivir plus anti-inflammatory drug baricitinib for COVID-19 begins
NIH News, May 8, 2020 - Hopes rise on coronavirus drug remdesivir
H Ledford, Nature News, April 30, 2020 - Antiviral remdesivir prevents disease progression in monkeys with COVID-19
Study supports clinical testing under way across U.S.
NIH News release, APril 17, 2020 - Pursuing Safe and Effective Anti-Viral Drugs for COVID-19
NIH Director's blog, April 17, 2020 - Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)- A Review
JAM Sanders et al, JAMA, April 13, 2020 - NIH clinical trial of remdesivir to treat COVID-19 begins
NIH, February 25, 2020
About RCH PHGKB
Reproductive and Child Health PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to reproductive and child Health...more
Content Summary
Common RCH Related Topics
- Attention Deficit/Hyperactivity Disorder
- Autism
- Birth Defects
- Carrier Testing
- Cerebral Palsy
- Congenital heart defects
- Pregnancy loss
- Developmental Disabilities
- Gestational Diabetes
- Hearing loss
- Neural tube defects
- Infant Mortality
- Infertility
- Learning disability
- Newborn Screening
- Preeclampsia
- Prematurity
- Prenatal Testing
- Stillbirth
- Sudden Infant Death Syndrome
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 07, 2024
- Content source: